Resultats globals: 5 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
6 p, 377.9 KB Clinical and genetic differences between pustular psoriasis subtypes / Twelves, Sophie (King's College London) ; Mostafa, Alshimaa (Beni Suef University) ; Dand, Nick (King's College London) ; Burri, Elias (University Hospital Zurich (Suïssa)) ; Farkas, K. (University of Szeged) ; Wilson, Rosemary (King's College London) ; Cooper, Hywel L. (Portsmouth Hospitals Trust) ; Irvine, Alan D. (Trinity College Dublin) ; Oon, Hazel H. (National Skin Centre) ; Kingo, Külli (Tartu University Hospital (Tartu, Estònia)) ; Köks, Sulev (University of Tartu) ; Mrowietz, Ulrich (University Medical Center Schleswig-Holstein) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Reynolds, Nick (Newcastle Hospitals NHS Foundation Trust) ; Tan, Euegene Sern-Ting (National Skin Centre) ; Tanew, Adrian (Medical University of Vienna) ; Torz, Kaspar (Campus Kiel) ; Trattner, Hannes (Medical University of Vienna) ; Valentine, Mark (University of Washington School of Medicine) ; Wahie, Shyamal (University Hospital of North Durham and Darlington Memorial Hospital) ; Warren, Richard B. (University of Manchester and the Academic Health Science Centre) ; Wright, Andrew (St University of Bradford) ; Bata-Csörgő, Zsuzsa (University of Szeged) ; Szell, Marta (University of Szeged) ; Griffiths, Christopher E.M. (University of Manchester and the Academic Health Science Centre) ; Burden, A.David (University of Glasgow) ; Choon, Siew-Eng (Monash University Malaysia) ; Smith, Catherine H. (King's College London) ; Barker, Jonathan N. (King's College London) ; Navarini, Alexander A. (University Hospital Zurich (Suïssa)) ; Capon, Francesca (King's College London) ; Universitat Autònoma de Barcelona
The term pustular psoriasis indicates a group of severe skin disorders characterized by eruptions of neutrophil-filled pustules. The disease, which often manifests with concurrent psoriasis vulgaris, can have an acute systemic (generalized pustular psoriasis [GPP]) or chronic localized (palmoplantar pustulosis [PPP] and acrodermatitis continua of Hallopeau [ACH]) presentation. [...]
2019 - 10.1016/j.jaci.2018.06.038
The Journal of Allergy and Clinical Immunology, Vol. 143 Núm. 3 (march 2019) , p. 1021-1026  
2.
3 p, 1.3 MB Vaccine hesitancy and access to psoriasis care during the -19 pandemic : findings from a global patient-reported cross-sectional survey / Bechman, Katie (King's College London) ; Cook, Emma S. (King's College London) ; Dand, Nick (Health Data Research UK) ; Yiu, Zenas Z.N. (The University of Manchester) ; Tsakok, Teresa (King's College London) ; Meynell, Freya (King's College London) ; Coker, Bolaji (King's College London) ; Vincent, Alexandra (King's College London) ; Bachelez, Hervé (Université de Paris) ; Barbosa, Ines (King's College London) ; Brown, Matthew A. (King's College London) ; Capon, Francesca (King's College London) ; Contreras, Claudia R. (Universidad Nacional de Asuncion) ; De La Cruz, Claudia (Clinica Dermacross) ; Di Meglio, Paola (King's College London) ; Gisondi, Paolo (University of Verona) ; Jullien, Denis (Groupe de recherche sur le psoriasis (GrPso) de la Société Française de dermatologie) ; Kelly, Jade (NIHR Manchester Biomedical Research Centre) ; Lambert, Jo (Ghent University) ; Lancelot, Camille (International Federation of Psoriasis Associations) ; Langan, Sinead M. (London School of Hygiene and Tropical Medicine) ; Mason, Kayleigh J. (Keele University) ; McAteer, Helen (The Psoriasis Association) ; Moorhead, Lucy (King's College London) ; Naldi, Luigi (Centro Studi GISED) ; Norton, Sam (King's College London) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Spuls, Phyllis I. (Amsterdam UMC. University Medical Center) ; Torres, Tiago (Centro Hospitalar do Porto) ; Urmston, Dominic (The Psoriasis Association) ; Vesty, Amber (The Psoriasis Association) ; Warren, Richard B. (NIHR Manchester Biomedical Research Centre) ; Waweru, Hoseah (International Federation of Psoriasis Associations) ; Weinman, John (King's College London) ; Griffiths, Christopher E.M. (NIHR Manchester Biomedical Research Centre) ; Barker, Jonathan (King's College London) ; Smith, Catherine H. (King's College London) ; Galloway, James B. (King's College London) ; Mahil, Satveer K. (King's College London) ; Universitat Autònoma de Barcelona
2022 - 10.1111/bjd.21042
British journal of dermatology, Vol. 187 (may 2022) , p. 254-256  
3.
18 p, 504.6 KB Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure / Armstrong, April W (Keck School of Medicine of the University of Southern California. Department of Clinical Research) ; Paul, Carle (Paul Sabatier University. Dermatology Department, Toulouse University Hospital (CHU)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Boehncke, Wolf-Henning (University of Geneva. Department of Pathology and Immunology) ; Freeman, Michael (The Skin Centre, Benowa, QLD Australia) ; Torii, Hideshi (Tokyo Yamate Medical Center. Division of Dermatology) ; Papp, Kim (K Papp Clinical Research and Probity Medical Research) ; Griffiths, Christopher E. M. (NIHR Manchester Biomedical Research Centre. Dermatology Centre, Salford Royal Hospital, University of Manchester) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Reich, Kristian (Skinflammation® Center, Hamburg, Germany) ; Gooderham, Melinda (Centre for Dermatology and Probity Medical Research, Peterborough, ON Canada) ; Terui, Tadashi (Nihon University School of Medicine. Department of Dermatology) ; Renda, Lisa (Eli Lilly and Company) ; Agada, Noah (Eli Lilly and Company) ; Xu, Wen (Eli Lilly and Company) ; Gallo, Gaia (Eli Lilly and Company) ; Lebwohl, Mark G. (Icahn School of Medicine at Mount Sinai. Department of Dermatology) ; Universitat Autònoma de Barcelona
Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the treatment of moderate-to-severe plaque psoriasis. We examined the safety and tolerability of up to 5 years of ixekizumab therapy in patients with psoriasis. [...]
2019 - 10.1007/s13555-019-00340-3
Dermatology and Therapy, Vol. 10 (november 2019) , p. 133-150  
4.
1 p, 320.3 KB Correction to : Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3) / Blauvelt, Andrew (SW Locust St., Suite G, Portland, OR 97223 USA) ; Papp, Kim A. (Waterloo, Canada) ; Griffiths, Christopher E. M. (Manchester, UK) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Weisman, Jamie (Medical Dermatology Specialists, Inc., Atlanta, GA USA) ; Dutronc, Yves (Indianapolis, IN USA) ; Kerr, Lisa Farmer (Indianapolis, IN USA) ; Ilo, Dapo (Indianapolis, IN USA) ; Mallbris, Lotus (Indianapolis, IN USA) ; Augustin, Matthias (University Medical Center Hamburg-Eppendorf) ; Universitat Autònoma de Barcelona
2018 - 10.1007/s40257-018-0353-x
American Journal of Clinical Dermatology, Vol. 19 (march 2018) , p. 457  
5.
8 p, 420.3 KB Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders : a Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3) / Blauvelt, Andrew (SW Locust St., Suite G, Portland, USA) ; Papp, Kim A. (Waterloo, Canada) ; Griffiths, Christopher E. M. (Manchester, UK) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Weisman, Jamie (Medical Dermatology Specialists, Inc., Atlanta, GA USA) ; Dutronc, Yves (Indianapolis, IN USA) ; Kerr, Lisa Farmer (Indianapolis, IN USA) ; Ilo, Dapo (Indianapolis, IN USA) ; Mallbris, Lotus (Indianapolis, IN USA) ; Augustin, Matthias (University Medical Center Hamburg-Eppendorf) ; Universitat Autònoma de Barcelona
Patients with psoriasis who have an inadequate response to one biologic may benefit from switching to a new biologic, such as ixekizumab, a high affinity monoclonal antibody that selectively targets interleukin (IL)-17A. [...]
2017 - 10.1007/s40257-016-0246-9
American Journal of Clinical Dermatology, Vol. 18 (january 2017) , p. 273-280  

Vegeu també: autors amb noms similars
1 Griffiths, C. M.
3 Griffiths, C.E.M.
1 Griffiths, C.J.
1 Griffiths, Chris E.M.
3 Griffiths, Christopher E. M.
2 Griffiths, Christopher E.M.
1 Griffiths, Christopher EM.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.